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Abstract
Background: Acute ozone exposure causes lung oxidative stress and inflammation leading to lung injury. At least
one mechanism underlying the lung toxicity of ozone involves excessive production of reactive oxygen and
nitrogen intermediates such as peroxynitrite. In addition and beyond its major prooxidant properties, peroxynitrite
may nitrate tyrosine residues altering phosphorylation of many protein kinases involved in cell signalling. It was
recently proposed that peroxynitrite activates 5’-AMP-activated kinase (AMPK), which regulates metabolic pathways
and the response to cell stress. AMPK activation as a consequence of ozone exposure has not been previously
evaluated. First, we tested whether acute ozone exposure in mice would impair alveolar fluid clearance, increase
lung tissue peroxynitrite production and activate AMPK. Second, we tested whether loss of AMP-activated protein
kinase alpha1 subunit in mouse would prevent enhanced oxidative stress and lung injury induced by ozone
exposure.
Methods: Control and AMPKa1 deficient mice were exposed to ozone at a concentration of 2.0 ppm for 3 h in
glass cages. Evaluation was performed 24 h after ozone exposure. Alveolar fluid clearance (AFC) was evaluated
using fluorescein isothiocyanate tagged albumin. Differential cell counts, total protein levels, cytokine
concentrations, myeloperoxidase activity and markers of oxidative stress, i.e. malondialdehyde and peroxynitrite,
were determined in bronchoalveolar lavage (BAL) and lung homogenates (LH). Levels of AMPK-Thr
172
phosphorylation and basolateral membrane Na(+)-K(+)-ATPase abundance were determined by Western blot.
Results: In control mice, ozone exposure induced lung inflammation as evidence by increased leukocyte count,
protein concentration in BAL and myeloperoxidase activity, pro-inflammatory cytokine levels in LH. Increases in
peroxynitrite levels (3 vs 4.4 nM, p = 0.02) and malondialdehyde concentrations (110 vs 230 μmole/g wet tissue)
were detected in LH obtained from ozone-exposed control mice. Ozone exposure consistently increased
phosphorylated AMPK-Thr
172 to total AMPK ratio by 80% in control mice. Ozone exposure causes increases in AFC
and basolateral membrane Na(+)-K(+)-ATPase abundance in control mice which did not occur in AMPKa1 deficient
mice.
Conclusions: Our results collectively suggest that AMPK activation participates in ozone-induced increases in AFC,
inflammation and oxidative stress. Further studies are needed to understand how the AMPK pathway may provide
a novel approach for the prevention of ozone-induced lung injury.
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Ambient ozone is a secondary pollutant formed through
a complex series of photochemical reactions involving
nitrogen oxides and sunlight. Ozone inhalation causes
airway inflammation, direct epithelial injury and
decreased lung function in both animal and human stu-
dies [1]. Ozone is highly reactive and oxidizes proteins
and lipids in the fluid-lining compartment of the lung,
which initiates inflammation processes and increased
lung permeability. At least one mechanism underlying
the lung toxicity of ozone involves excessive production
by airway epithelial cells and activated lung immune
cells of cytotoxic mediators including pro-inflammatory
cytokines, reactive oxygen and nitrogen intermediates
such as peroxynitrite [2,3].
Peroxynitrite is an extremely powerful and cytotoxic
oxidant, which not only oxidizes lipids, nucleic acids,
and protein SH-groups, but also nitrates aromatic
amino acid protein residues. Via nitration of tyrosine
residues, peroxynitrite alters the function of many pro-
teins, such as superoxide dismutase, prostacyclin
synthase PGI2,C a
2+-ATPase, glutathione s-transferase,
as well as transcriptional factors [4,5]. Observations that
peroxynitrite induces nitration of tyrosine residues and
also alters tyrosine phosphorylation have focused atten-
tion on phosphorylation cascades, as phosphorylation of
mitogen-activated protein kinases modulate many cell
signaling processes [4,6]. Moreover, it was recently pro-
posed that peroxynitrite strongly increases phosphoryla-
tion of constitutive nitric oxide synthase via 5’-AMP-
activated kinase activation, which results in enhanced
production of reactive oxygen species contributing to a
further oxidative damage [4].
5’-AMP-activated protein kinase (AMPK) is a serine
threonine kinase that is highly conserved through evo-
lution. As a cellular metabolic sensor, AMPK acts on a
wide variety of substrates and cellular pathways,
including the regulation of metabolic pathways (e.g.,
glycolysis, fatty acid synthesis and oxidation, cellular
glucose uptake, and cholesterol synthesis), apoptosis
and the cell cycle. It is becoming increasingly recog-
n i z e dt h a tc h a n g e si nA M P Kactivation are also impli-
cated in several signaling pathways involved in nitric
oxide production, sensing and responding to oxidative
stress, and inflammation [7-9]. Downstream effects of
AMPK activation may differ depending upon tissue
stress intensity and metabolic needs. In peripheral
organs such as the heart, activation of AMPK during
ischemia reperfusion reduces damage [10]. In the
brain, activation of AMPK during low-energy states
such as ischemia is detrimental [11]. In the lung,
AMPK activation following hypoxic challenge results
in pulmonary vasoconstriction and transepithelial
Na
+ transport inhibition [12]. Hence, biological
consequences of stress-mediated AMPK activation are
complex and remain highly variable.
Alterations in AMPK activation as a consequence of
ozone exposure have not been previously evaluated. It is
likely that production of peroxynitrite induced by ozone
exposure may activate AMPK, which in turn could mod-
ulate transepithelial ion transport, oxidative stress and
inflammation. Our objectives were twofold. First, we
tested whether acute ozone exposure in mice would
impair alveolar fluid clearance, increase lung tissue per-
oxynitrite production and activate AMPK. Second, we
tested whether loss of AMP-activated protein kinase
alpha1 subunit in mouse would prevent enhanced oxida-
tive stress and lung injury induced by ozone exposure.
Methods
Animal used
Control and AMPKa1K Om a l em i c e( 1 2 9 / S va n d
C57BL/6 mixed background) were studied at 20-24 wk
of age. Animals were housed under controlled tempera-
ture and lighting with free access to water and standard
mouse chow diet. All procedures were performed in
accordance with the principles and guidelines estab-
lished by the European Convention for the Protection of
Laboratory Animals. All animal studies were approved
by the Institutional Review Board of the National Insti-
tute (Agreement number 59-350146, Direction départe-
mentale de Protection des Populations DDPP, Nord,
France).
Ozone exposure
Exposure to ozone [2 parts/million (ppm) for 3 h] or fil-
tered room air in conscious mice was conducted in a
stainless steel chamber with a Plexiglas door (~2.5 liters
in volume). Ozone was generated by passing dry 100%
oxygen through ultraviolet light and mixing it with fil-
tered room air in the chamber. Chamber atmosphere
was drawn continuously via a sampling port, and ozone
concentration was measured by an ozone chemilumines-
cent analyzer (Model 49I; Thermo-environmental
Instruments, Franklin, Massachussetts, USA). Chamber
air temperature and relative humidity were maintained
constant throughout experiments. Mice were then
allowed to recover in ambient air for 24 h. Mice were
then euthanized with an i.p. injection of a mixture of
ketamine and xylazine (100 mg/kg and 20 mg/kg
respectively).
Bronchoalveolar lavage (BAL)
Mice were sacrificed, and the trachea was cannulated
w i t ha2 0 - g a u g ec a t h e t e r .B A Lw a sp e r f o r m e dt w i c e
with 0.8 ml of ice-cold PBS (pH 7.4) each. At least 1
mL of injected volume was recovered in all mice. The
BAL fluid was spun at 800 g for 5 min at 4°C, and
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proteins. Total proteins from cell free supernatant of the
BAL fluids were assessed using the Bradford Assay
(BioRad, CA). Pelleted cells were harvested, and red
cells were lysed, then washed and resuspended in cold
PBS. Total cells were enumerated by counting on a
hemocytometer. For differential cell counting, cells were
spun onto glass slides, air-dried, fixed in ethanol, and
stained with Diff-Quick reagents (Baxter Scientific,
Miami, FL). The number of macrophages, neutrophils
and lymphocytes was counted based on morphology.
Myeloperoxidase activity, malondialdehyde level and
peroxynitrite content in lung homogenates
Animals were euthanized and perfused with cold saline
via the heart. The left lobes were removed and homo-
genized in 1 ml of PBS containing complete protease
i n h i b i t o rc o c k t a i l( S i g m a ,S t .L o u i s ,M O ) .T h e n ,t h e
samples were centrifuged for 10 min at 800 g. Super-
natants were filtered and kept in -70°C until used.
Myeloperoxidase (MPO) activity, an indicator of poly-
morphonuclear leukocyte (PMN) accumulation, was
determined as previously described [13]. Briefly, fol-
lowing lung homogenate preparation, myeloperoxidase
activity was determined by measuring hydrogen perox-
ide-dependent oxidation of 3,3’,5,5’-tetramethylbenzi-
dine. The rate of change in absorbance was measured
spectrophotometrically at 650 nm. Myeloperoxidase
activity was defined as the quantity of enzyme degrad-
ing 1 μmol of peroxide min
-1 at 37°C and was
expressed in units per gram weight of wet tissue. Mal-
ondialdehyde (MDA) level was utilized to quantify the
lipid peroxidation in tissues as previously described
[14]. Briefly, following lung homogenate preparation,
MDA content was based on the reaction of MDA with
thiobarbituric acid at 90-100°C. Samples were then
heated for 1 h at 95°C and centrifuged at 3000 g for
10 min. The absorbance of the supernatant was mea-
sured by spectrophotometry at 532 nm using 1,1,3,3-
tetramethoxypropane as an external standard. MDA
was expressed in micromole per g weight of wet tissue.
The formation of peroxynitrite was estimated by
means of peroxynitrite-dependent oxidation of dihy-
drorhodamine-123 (DHR123, Molecular Probes,
Eugene, Oregon) to rhodamine as previously described.
This method is an indirect measurement of peroxyni-
trite production since other oxidant species can oxidize
dihydrorhodamine-123 [15]. Briefly, duplicate aliquots
of lung homogenate supernatants incubated with 5 μM
DHR123 were taken for rhodamine fluorescence eva-
luation using a fluorometer at an excitation wavelength
of 500 nm and an emission wavelength of 530 nm. A
fluorescence standard curve was obtained with authen-
tic rhodamine and results were expressed in nmol/L.
Multiplex for detection of cytokines
Lung homogenate supernatants were assayed for a panel
of cytokines and chemokines (IFN-g,I L - 1a,I L - 1 b,
TNF-a, IL-6, IL-10, IL-2, IL-4, IL-5, IL-7, IL-9, IL-10,
IL-12p40/p70, IL-13, IL-15, IL-17, IP-10, MCP-2, G-
CSF, MIP-1a, GM-CSF, and RANTES) using a multi-
plex-assay (xMAP Luminex Bioplex 200, Luminex Corp,
Biorad, France) according to the manufacturer’si n s t r u c -
tions. All samples were assayed in duplicate and results
were calculated as pg/mL.
Alveolar fluid clearance
After sacrifice, the trachea was cannulated by using a
20-gauge catheter. The lungs were then inflated with 7
cm H2O continuous airway pressure with 100% oxygen
throughout the experiment. An infrared lamp placed
above the body maintained body temperature at 37°C.
The lungs were instilled with Ringer lactate containing
5% bovine serum albumin and fluorescein isothiocya-
nate-tagged albumin as an alveolar protein tracer.
Osmolarity of the instillate was adjusted to 340 mosM,
which we have shown to be isosmolar with mouse
plasma. Alveolar fluid clearance (AFC) was measured
over 15 min. As in previous studies, AFC was deter-
mined by measuring the increase in the final fluores-
cence intensity of the alveolar protein tracer compared
with the initial instilled tracer protein fluorescence
intensity [16,17]. AFC was calculated as AFC = 1-(C1/
C2), where C1 is the fluorescence intensity of the initial
instilled tracer protein and C2 is the final total tracer
protein fluorescence intensity in the alveolar fluid.
Basolateral cell membrane isolation
Pieces of peripheral lung tissue were collected from each
lobe and homogenized to obtain whole cell lysates (each
piece approximately represented a cube of 2 millimeters
side). Cells were prepared by addition of lysis buffer and
centrifugation at 14,000 g to eliminate the insoluble
material. Basolateral membranes were prepared using
ultracentrifugation as previously described [18]. Periph-
eral lung tissue was homogenized and centrifuged twice
to discard the nuclear and mitochondrial pellet. Super-
natant was centrifuged at 48,000 g for 30 min, and the
basolateral membrane fraction was recovered after the
membrane pellet was centrifuged in a 16% Percoll gradi-
ent at 48,000 g for 30 min.
Western blot analysis
Proteins from cell lysates and basolateral membrane
fractions were resolved by 10% SDS-PAGE and ana-
lyzed by immunoblotting. Mouse monoclonal antibo-
dies anti total AMPK-a (Cell Signaling, France) and
rabbit monoclonal antibodies anti-phospho-AMPK-a
at Thr172 (Cell Signaling, France) were used for cell
Hulo et al. Respiratory Research 2011, 12:64
http://respiratory-research.com/content/12/1/64
Page 3 of 8lysate immunoblotting. Mouse monoclonal antibody
anti-Na,K-ATPase alpha1 (Upstate Biotechnology, Lake
Placid, NY) and rabbit polyclonal antibody anti-
GLUT1 (Millipore, France) were used for basolateral
membrane fractions immunoblotting, respectively.
AMPK activation was assessed as the ratio of phospho-
AMPK to total AMPK. GLUT1 was measured by
immunoblotting as a loading control for plasma mem-
brane protein. The amount of Na,K-ATPase at the
plasma membrane was normalized to GLUT1.
Statistical analysis
All statistical analyses were performed using GraphPad
Prism 5.0 (GraphPad Software Inc., San Diego, CA).
When a significant difference was found, we examined
between-group differences using a sequentially rejective
Bonferroni procedure. After applying Bonferroni’sc o r -
rection, the level of statistical significance was set at p <
0.05 for comparisons with control. Experimental results
were expressed as mean ± S.D.
Results
Ozone exposure induces lung inflammatory
In the first part of our study, we observed the impact of
acute ozone exposure on lung inflammation. We there-
fore evaluated cell recruitment and total protein level in
the BAL. We found a significant increase in proportion
of neutrophils in the ozone-exposed mice BAL (Figure
1). The recruitment of neutrophils observed in mice
BAL has been confirmed in lung homogenates by mea-
surement of MPO activity which was significantly higher
in ozone-exposed mice than in control mice (p = 0.037)
(Table 1). The total protein was also higher in ozone-
exposed mice BAL than in control mice. We also
showed a significant increase in major pro-inflammatory
cytokine levels such as IL-6 and IL-1b in ozone-exposed
mice lung homogenates (Figure 1).
Ozone exposure increases lung oxidative stress
There were significant increases in oxidation of DHR123
(p = 0.02) and MDA concentration (p < 0.0001) in
ozone-exposed mice lung homogenates (Table 1).
Ozone exposure increases AMPK phosphorylation
As we observed a peroxynitrite increase in ozone-
exposed mice lung homogenates, we next evaluated
AMPK phosphorylation. There was a strong increase of
phospho-AMPK to total AMPK ratio in ozone-exposed
mice lung homogenates compared with the unexposed
group (p = 0.04) (Figure 2).
Ozone exposure increases alveolar fluid clearance
As we observed an increase in the total protein in BAL
of mice exposed to ozone, which indicated an increase
in crude epithelial permeability, we explored the effects
of ozone on the alveolar fluid clearance increase. So, we
hypothesized that activation of Na,K-ATPase contributes
to the increase in clearance of alveolar fluid. There was
a significant increase of alveolar fluid clearance in
ozone-exposed control mice (p = 0.05). We then wanted
Figure 1 Effects of ozone exposure on lung inflammation in
control mice. Total protein concentration (A), total cell count and
neutrophil count (% × 1 000) (B) in BAL fluid and pro-inflammatory
cytokine levels (C) in lung homogenates were measured as markers
of pulmonary inflammation. Ozone-exposed groups were exposed
to air containing 2 ppm ozone continuously for 3 h. Parameters
were evaluated 24 h after exposure. Data are presented as means ±
SD. *p < 0.05, when compared with non-exposed mice (n = 10 in
control group and n = 8 in ozone-exposed group). BAL:
bronchoalveolar lavage; TNF-a: tumor necrosis factor alpha; IL1b:
interleukin 1 beta; IL6: interleukin 6
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the increased alveolar fluid clearance. Basolateral mem-
brane Na,K-ATPase abundance normalized to GLUT1-
was twofold higher in ozone-exposed control mice
(Figure 3).
AMPKa1 deficient mice are protected from ozone lung
injury
There were no changes in MPO activity, MDA concen-
tration and peroxynitrite levels in AMPKa1 deficient
mice after ozone exposure (Table 1). Alveolar fluid
clearance did not change significantly in AMPKa1d e f i -
cient mice after ozone exposure (Figure 3). The
basolateral membrane Na,K-ATPase abundance was not
different between the exposed and unexposed group in
AMPKa1 deficient mice.
Discussion
Because AMPK has been shown to modulate airway
transepithelial ion transport, inflammation and oxidative
stress, we tested the hypothesis that AMPK deficiency
would prevent ozone-induced lung injury in mice.
Important findings of this study revealed that acute
ozone exposure increase lung fluid clearance, leukocyte
infiltration and oxidative stress and that ozone-induced
lung injury was largely prevented in AMPK alpha1 sub-
unit deficient mice.
Acute inhalation of ozone was found to cause struc-
tural alterations in the lung including disruption of the
alveolar epithelial barrier, followed by alveolar epithelial
type II cell hypertrophy and hyperplasia. Recruitment of
inflammatory cells into the lung following O3 exposure
presents another risk of tissue damage through the
release of toxic mediators by activated macrophages and
neutrophils inflammatory cells, including cytokines,
reactive oxygen and nitrogen species and proteolytic
enzymes [1]. Following ozone inhalation, TNF-a levels
rapidly peaked, predominantly in alveolar macrophages
and has been implicated in lung injury by stimulating
the production of cytotoxic inflammatory mediators
such as cytokines and chemokines. In rodents, many of
the pulmonary manifestations of acute O3 exposure
have been attributed to the effects of these cytokines
and chemokines, as interruption of IL-1, IL-6, signaling
significantly diminishes O3-induced neutrophil emigra-
tion to the airspaces and/or epithelial cell injury.
Twenty-four hours after exposure early TNF-a peak
concentration was not detected, whereas concentrations
of IL-1 and IL-6 increased in BAL of ozone-exposed
mice. This is consistent with previous studies indicating
that cytokine secretion profiles are related to compart-
mentalization and migration of different inflammatory
cell-types during the development of ozone injury [1-3].
In addition, characteristics of recruitment of inflamma-
tory cells in mice lung following ozone exposure have
been shown varying with ozone concentration, exposure
Table 1 MDA levels, MPO activity and peroxynitrite levels in lung homogenates WT or AMPKa1 deficient mice
control mice AMPKa1 deficient mice
Air Ozone Air Ozone
MDA (μmol/g wet tissue) 110 +/- 14.1* 230 +/- 10* 160 +/- 13 147 +/- 12.6 *p < 0.0001
MPO (U/g wet tissue) 0.13 +/- 0.03* 0.27 +/- 0.04* 0.13 +/- 0.02 0.16 +/- 0.06 *p = 0.04
Peroxynitrite (nmol/L) 3.0 +/- 0.2* 4.4 +/- 1.0* 2.8 +/- 0.5 2.8 +/- 0.4 *p = 0.03
Mice were exposed to air with or without ozone at 2 ppm for 3 h. Parameters were evaluated 24 h after exposure. Malondialdehyde (MDA) was expressed as
micromole per g weight of wet tissue; Myeloperoxidase activity (MPO) was expressed in units per gram weight of wet tissue. Peroxynitrite was expresseda s
nmol/L. Data are presented as means ± SD. *: p < 0.05; μmol/g wet tissue: micromole per g weight of wet tissue; U/g wet tissue: units per gram weight of wet
tissue
Figure 2 P(Thr172)-AMPK to total AMPK ratio in control mice
lung homogenates. P(Thr
172)-AMPK to total AMPK ratio (A) and
Western Blot analysis (B) were performed in control mice lung
homogenates. Mice were exposed or not to ozone at 2 ppm for 3
h. Parameters were evaluated 24 h after exposure. Data are
presented as means ± SD. *: p < 0.05; (n = 6 in each group). AMPK:
adenosine monophosphate activated protein kinase
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129sv mice used in our model are strong responders for
the lung response to O3 [19] and seem to be little
affected by age in term of O3 response [20]. Consis-
tently, our model of acute ozone exposure (3 h, 2 ppm)
elicited alveolar neutrophil recruitment and increases in
biomarkers of lung tissue inflammation and oxidative
stress. Expression of concentrations of biomarkers per
gram of wet lung in this study would have caused us to
underestimate increases in MDA, MPO and peroxyni-
trite levels, as O3 exposure likely induced edema forma-
tion leading to increases in lung wet weight, which we
used as a normalization parameter.
Fluid and solute resorption from the alveolus is critical
in clearing fluid from lungs [21]. Active alveolar epithelial
Na
+ ion transport is well established as the primary
mechanism of fluid clearance from distal airspaces [22].
In the current model of fluid balance in the distal lung,
Na
+ ions enter alveolar type II epithelial cells at the apical
surface primarily through amiloride-sensitive sodium
channels and are pumped out on the basolateral surface
by Na,K-ATPase. In conditions of lung inflammation,
such as ozone exposure, active Na
+ transport and alveo-
lar fluid clearance may be stimulated leading to increased
ability of the lungs to clear edema. Indeed, a large variety
of endogenous mediators, which are released by the lung
in response to ozone exposure, may be responsible for
the stimulation of alveolar liquid clearance. For example,
increased TNF-alpha production has been consistently
shown to stimulate alveolar fluid transport [23]. Likewise,
authentic nitric oxide and nitrogen intermediates have
been shown to modulate active Na
+ transport in alveolar
type 2 epithelial cells, and both stimulation [24] and inhi-
bition [25] of transport characteristics have been
reported. Hence, it may be hypothesized that alveolar
fluid clearance increase observed in our ozone exposure
model may be the result of ozone-induced proinflamma-
tory cytokine and peroxynitrite increases.
Concomitant changes in permeability, oxidative stress
and recruitment of inflammatory cells in the lung follow-
ing ozone exposure have been shown varying with ozone
concentration, exposure duration, and animal species [1].
The exact mechanism influencing the severity of ozone-
induced pulmonary reaction and molecules involved in
the modulation of this response are yet to be fully deter-
mined. Proposed mechanisms include the regulation of
the oxidant anti-oxidant balance through functionally
relevant post-translational protein modification. In this
context, peroxynitrite can play an important role in this
balance through the nitration of tyrosine residues that
alters the function of many proteins, such as superoxide
dismutase and NADPH oxidase [6]. In addition, via
increased c-Src, phosphatidylinositol 3-kinase or protein
kinase C activities, peroxynitrite may also activate
AMPK, which has been shown to alter cell response to
oxidative stress [26-28]. In our study, we confirmed that
increased lung peroxynitrite production was associated
with AMPK phosphorylation in ozone-exposed mice.
Importantly, AMPK alpha1 subnunit deficient mice were
protected against ozone-induced lung injury, suggesting
that AMPK activation was detrimental.
Figure 3 Alveolar fluid clearance and basolateral membrane
Na,K-ATPase abundance in WT or AMPKa1 deficient mice. (A)
Alveolar fluid clearance (%) in wild type or AMPKa1 deficient mice
exposed (n = 3) or not (n = 4) to ozone at 2 ppm for 3 h. (B)
Western Blot analysis of Na,K-ATPase expression at the plasma
membrane in wild type or AMPKa1 deficient mice exposed (n = 3)
or not (n = 4) to ozone at 2 ppm for 3 h. The amount of Na,K-
ATPase was normalized to GLUT1. Results were expressed in fold
increased of control. Mice were exposed to air with or without
ozone at 2 ppm for 3 h. Parameters were evaluated 24 h after
exposure; *: p < 0.05; GLUT1: glucose transporter 1.
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a catalytic a subunit and regulatory b and g subunits.
The a1a n da2 subunit isoforms have ~90% homology
in their N-terminal catalytic domains and ~60% homol-
ogy in their C-terminal domains, suggesting that they
may have distinct downstream targets. For example,
AMPKa2 deletion results in mild insulin-resistance and
impaired glucose tolerance, whereas deletion of
AMPKa1 has no detectable effects on metabolic pheno-
type. In addition and beyond the regulation of energy
homeostasis, AMPK also exerts non-metabolic func-
tions, such as maintenance of cell polarity and normal
cell division, or control of cell growth and survival [29].
In lung cells, the a1 catalytic subunit of AMPK is pre-
dominantly expressed and its pharmacological activation
leads to inhibition of Na
+ transport processes across
lung epithelium [30]. It has been previously reported
that AMPK activation inhibits Na
+ transport processes
across lung epithelium via PKCzeta activation and Na,K-
ATPase endocytosis, whereas inhibition of AMPK by
compound C enhances Na
+ transport [31]. In our
model, lung AMPK phosphorylation observed in control
mice exposed to ozone was not associated with expected
inhibition of Na
+ transport processes across lung epithe-
lium and Na,K-ATPase endocytosis related to AMPK
activation. Instead, ozone exposure induced increases in
alveolar fluid clearance and the presence of Na,K-
ATPase at the plasma membrane. Yet, increases in
alveolar fluid clearance and plasma membrane Na,K-
ATPase abundance were not observed in AMPKa1 defi-
cient mice exposed to ozone, suggesting that AMPK
activation modulates mechanisms involved in Na
+ trans-
port processes across lung epithelium independent of
Na,K-ATPase activity.
Hence, we next reasoned that protection against
ozone-induced lung injury in AMPKa1d e f i c i e n tm i c e
was related to the reduction of oxidative stress and leu-
kocyte lung infiltration. Under conditions of cell stress,
the actions of AMPK are mainly dependent on cell type
and metabolism [32]. AMPK activation is beneficial in
peripheral tissues, such as the ischemic heart [10]. How-
ever, AMPK activation may exacerbate brain oxidative
stress and injury whereas its pharmacological inhibition
provided neuroprotection in the ischemic and reper-
fused brain [33,34]. It has been proposed that in cells
lacking key glycolytic enzymes and/or with limited abil-
ity to store nutrients such as neurons, AMPK activation
leads to acidosis, enhanced oxidative stress and cell
apoptosis [35]. It is, hence, our contention that in lung
epithelial cells, which have low nutrient storage capa-
city, AMPK activation may be detrimental and that
defect in AMPKa1 may be protective by limiting
ozone-induced lung oxidative stress. Another common
feature of the host response to ozone is neutrophilic
inflammation and up-regulation of proinflammatory
cytokines. Recent evidence suggests that AMPK partici-
pates in the modulation of the inflammatory response.
For example, it has been reported that pharmacological
activation of AMPK has anti-inflammatory effects [36],
whereas AMPKa1 deficient mice display normal
immune responses. As neutrophilic recruitment is
mainly redox-sensitive in the acute ozone-exposed lung,
we speculated that reduced lung leukocyte sequestration
was related to the decreased oxidative stress in
AMPKa1 deficient mice.
Conclusion
Our results collectively suggest that activation of AMPK
is detrimental in ozone-induced lung injury. The use of
AMPK a1k n o c k o u tm i c ec l e a r l ys h o w nt h a tA M P K
activation participates in ozone-induced increases in
lung fluid clearance, leukocyte infiltration and oxidative
stress. Further studies are needed to delimit the role of
AMPK pharmacological inhibition and to demonstrate
that manipulation of the AMPK pathway may provide a
novel approach for the prevention of ozone-induced
lung injury.
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